Working Group 4

Setting Up New Business Models and Ways to Invest in Paediatric Oncology Research and Drug Development

Led by Delphine Heenen (Unite2Cue) and Sam Blackman

(Initially led by Patricia Blanc (Unite2Cure) & Raphael Rousseau (Gritstone Oncology)

Composition: Sam Blackman, Patricia Blanc, Emmanuel Blin, Jean-Charles van den Branden San Daems, Delphine Heenen, Andy Pearson, Raphael Rousseau, Gilles Vassal


To explore and design a new business model for the development of innovative treatment for children with cancer that will consider:

  • Repurposing of adult drugs and first in child investigation,
  • Cooperation with academia
  • Intent to file principle
  • Funding through both Venture Capitals and Charities
  • Precompetitive public private partnerships
  • Derisking models

Publication by ACCELERATE and Key papers:

For more information, please contact
You can tweet using #ACCELERATEplatform